Chemours (CC) Other Accumulated Expenses (2015 - 2026)

Chemours' Other Accumulated Expenses history runs 12 years deep, the most recent figure standing at $97.0 million for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 3.0% year-over-year to $97.0 million in Q1 2026; TTM through Mar 2026 was $97.0 million, a 3.0% decrease from a year earlier, with the FY2025 full-year figure at $150.0 million, up 36.36% from the prior year.
• Other Accumulated Expenses retreated to $97.0 million in Q1 2026 per CC's latest filing, from $150.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $239.0 million in Q2 2022 and bottomed at $74.0 million in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $129.0 million (2023), against an average of $137.5 million.
• Across the five-year window, Other Accumulated Expenses soared 187.67% in 2022 and tumbled 40.48% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $74.0 million in 2022, then jumped by 74.32% to $129.0 million in 2023, then slipped by 14.73% to $110.0 million in 2024, then jumped by 36.36% to $150.0 million in 2025, then sank by 35.33% to $97.0 million in 2026.
• Per Business Quant, the three latest CC Other Accumulated Expenses figures stand at $97.0 million (Q1 2026), $150.0 million (Q4 2025), and $107.0 million (Q3 2025).